Loading stock data…
Outset Medical (OM)
$3.47-0.12 (-3.34%)
Market ClosedLast close Sep 8
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Outset Medical, Inc. in the Healthcare sector is trading at $3.47 with a market capitalization of $83M. Wall Street consensus targets $7.67 (3 analysts), implying a +120.9% move over the next 12 months. The stock is currently near its 52-week low of $3.00, remaining 18.4% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 22 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +120.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 22) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $31.64M↑ | $27.86M↓ | $28.87M↓ | $29.43M↓ | $31.42M |
| Gross Profit | $13.28M↑ | $12.10M↓ | $12.23M↑ | $11.59M↓ | $11.87M |
| Operating Income | -$15.68M↑ | -$16.92M↑ | -$17.63M↓ | -$15.81M↑ | -$16.86M |
| Net Income | -$17.98M↑ | -$18.98M↑ | -$19.49M↓ | -$17.84M↑ | -$18.54M |
Peer Comparison
JNJUNHPFE
Fundamentals
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-de...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$82.77M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-67.02%
Volume
Today's trading volume
255,205
Recent News
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock
Outset Medical (OM) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Outset Medical (OM) Q2 2026 Earnings Call Transcript
CEO highlights $40M HCA refresh deal as first major console fleet win.
Outset Medical Q2 Earnings Call Highlights
Outset Medical (NASDAQ:OM) reported second-quarter 2026 revenue of $31.6 million, up 1% from a year earlier and 14% sequentially, as the dialysis technology company cited commercial progress, improving margins and a new $40 million refresh agreement with HCA Healthcare. Chair and Chief Executive Of
Outset Medical Inc (OM) (Q2 2026) Earnings Call Highlights: Revenue Growth and Strategic HCA ...
Outset Medical Inc (OM) reports Q2 2026 revenue of $31.6 million, up 14% sequentially, with a significant gross margin improvement and a $40 million HCA refresh agreement extending through 2028.
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
Outset Medical (OM) delivered earnings and revenue surprises of -26.98% and +9.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?